AnalystConsensusTarget has increased revenue growth from 3.3% to 4.3%, increased profit margin from 5.8% to 7.0% and decreased future PE multiple from 17.1x to 11.7x.

Acquisition Of RED And Growth In Cell Therapy Propel Revenue And Margins In Imaging And Healthcare

Shared on01 May 25Fair value Decreased 6.27%

Shared on23 Apr 25

Shared on17 Apr 25Fair value Decreased 1.27%

Shared on09 Apr 25Fair value Decreased 1.26%

Shared on02 Apr 25Fair value Increased 2.14%

Shared on26 Mar 25

Shared on19 Mar 25Fair value Decreased 1.45%

Shared on12 Mar 25Fair value Increased 8.68%

Shared on01 May 25
Fair value Decreased 6.27%

Shared on17 Apr 25
Fair value Decreased 1.27%

Shared on09 Apr 25
Fair value Decreased 1.26%

Shared on02 Apr 25
Fair value Increased 2.14%

Shared on19 Mar 25
Fair value Decreased 1.45%

Shared on12 Mar 25
Fair value Increased 8.68%